Extraction Archives - Green Market Report

StaffJuly 1, 2021
shutterstock_742830484.jpg?fit=960%2C695&ssl=1

7min9730

Some people like to smoke cannabis, others like to eat it—and some like to vaporize it! As places around the world continue to legalize cannabis, businesses are realizing the opportunities to be had in this growing market. 

Each year, consumers look forward to innovations in technology. When it comes to cannabis vapes, the market is booming with new devices and tweaks to existing products. Entrepreneurs don’t want to miss the opportunity to create the next best vape.

Cannabis vape tech is taking off globally, and here are 3 reasons why:

Demand is Increasing

During the pandemic, many consumers have reported that their medical use of cannabis for mental health reasons has increased. In addition, more and more states are legalizing the medical and recreational use of cannabis. To meet the rising demand, and to accommodate new consumers, vaping technology is advancing rapidly.

Whether consumers prefer to use dry flower or oil in their vapes, there’s a device on the market designed to meet their needs. Pods, pens, and box mods—you name it, there’s a cannabis vape for it. Now that demand is increasing for cannabis vapes, new products are being designed to accommodate them.

To gain a competitive edge in the market, there are new vaporizers coming out. Some utilize technology for a more user-friendly experience, like disposable or pre-filled vapes. Others focus on sustainability to appeal to eco-conscious consumers. Features like longer battery life, self-cleaning, and the shatter-resistant casing will set cannabis vapes apart in a saturated market.

Producers are always racing to meet the needs of the market, and in 2021, the market is full of opportunities for innovative vape devices. Given how recently cannabis was legalized in many states and countries, there’s plenty of room for growth—the question is, who will capitalize on it first?

Fewer Consumers are Smoking

Given the global outbreak of respiratory illness, more consumers are moving away from smoking and gravitating towards vapes. When cannabis is vaporized, it’s consumed at a lower temperature than when it’s smoked. If cannabis is smoked, it will cause combustion, which can produce harmful byproducts. The consumer is not exposed to these chemicals when cannabis is vaporized.

As public awareness about the respiratory issues associated with smoking increases, vaping is on the rise. Not only does vaping cannabis help consumers give up smoking, but the devices are more discreet and easy to use.

Someone who’s transitioning from smoking to vaping may be unsure of where to begin. There are different vapes to start with for new users, designed for ease of use. These include pens, pods, and disposable vapes. As more and more consumers switch to vaping, we expect to see user-friendly devices become increasingly popular.

There has never been a better time to quit smoking than right now when COVID-19 is still making waves around the globe. The fate of the cannabis market seemed uncertain at the beginning, but now the trend is clear: vaping cannabis is on the rise.

Vape Tech Producers are Partnering with Cannabis Cultivators

There’s one main barrier to producing new vape technology: state regulations. With the implementation of PMTA (Premarket Tobacco Application) looming over the tobacco vaping industry, some worry that cannabis vapes will be the next target.

To counteract these issues, companies are moving away from producing cannabis and devices. Instead, they are only producing vapes and relying on partnerships with popular cannabis cultivation companies. Businesses can specialize in creating cannabis tech without being held up by the licenses and regulations associated with cultivation. 

By partnering with cannabis producers, vape manufacturers can place their sole focus on improving their products. They don’t need to worry about obtaining licenses if they partner with companies that already have them; instead, they can work on releasing the next innovative vape.

When businesses focus their resources exclusively on advancing the technology of vaporizers, advancements can be made that will transform the vaping industry.

Cannabis vape producers are trying to match the fast pace of the market in 2021. In recent years, there’s been an influx of cannabis consumers interested in vaping, and the pandemic has only accelerated that trend. 

We anticipate that as the demand for cannabis vaporizers increases, the technology will develop rapidly to appeal to new and seasoned vapers alike.

 


StaffJune 28, 2021
Vape-2.jpg?fit=960%2C640&ssl=1

7min9300

Editors Note: This is a guest post.

At Green Market Report, we like to focus on finances and analytics in the cannabis industry. In this article, however, we’re going to shift our focus a little bit – to fake vape cartridges.

Fake vape cartridges are a serious problem. They’re often made to mimic well-known brands, and they can reduce consumer confidence in the industry. Worse still – they can make you very sick, or even kill you if you don’t know how to spot them.

Unfortunately, the packaging for these vape cartridges can be incredibly professional. In this article, we’ll give you some tips on how you can spot the fakes. But first, a piece of advice:

Only buy from legal vendors and trusted brands

The easiest way to avoid fake vape cartridges is to only purchase from trusted sources. You can get lab test results from legal vendors, as cannabis producers have to provide them. In those test results, you can see exactly how much THC – and other chemicals – are present in the cartridge you’re purchasing.

Getting your products from trusted producers like PAX Labs, makers of the Era Pro, Era Life, PAX 2 and 3, will significantly reduce your risk of ending up with a fake vape cartridge.

Of course, this advice is only so good when you’re purchasing your cartridges online, or if you’re living in a state where cannabis is still a black market product. In light of that, here are a few tips for spotting fake products.

Know your brands

Websites like Leafly are incredibly good at listing reliable brands and reviews for those brands. Before you purchase or vape a cartridge, look up the brand and name on Leafly or a similar resource site. There are so many different vaporizer cartridges cataloged on these sites that if yours is legitimate, you’re almost sure to find it.  

Once you find the product in question, check reviews. You should also visit the website of the brand you’ve purchased. Then, compare the packaging you find with the packaging on your vape cartridge.

This is not a foolproof method – some of the nefarious actors creating these fake cartridges go out of their way to make their packaging match the real thing. Some of them create very high-quality websites. But doing your research can seriously help reduce your risk.

Check for regulatory compliance

This technique isn’t flawless, but it can help when you otherwise can’t tell whether or not the cartridge is legitimate. 

Check the regulatory requirements for vape cartridge packaging in your area. In California, for example, you’re required to have:

  • Manufacturer name and contact information
  • Date of manufacture/packaging
  • Government warning statement for cannabis products
  • UID number 
  • Batch or lot number
  • Instructions for use and any preparation needed
  • List of all ingredients 
  • Allergens
  • Artificial food colorings 
  • Expiration, use-by or best-by date

 

Check state laws or federal laws (in Canada) to see what information is required on the package, then check your package to see if it complies with those regulations. A weed store in Winnipeg is going to have different packaging requirements for its products than a weed store in Denver. 

Be suspicious of overly good deals

See a cartridge that promises 99.9% THC for $10?

Be very suspicious.

Check online or at your local licensed vendor to see how much cartridges go for, what ingredients they have, and the amount of THC in the cartridge. Compare those values to the values of the cartridge you’ve purchased – if things are drastically different, you probably have a fake cartridge.

Trust your gut

If something feels like it’s too good to be true, it probably is. You might not be able to tell by taste, smell, or sight. You might just feel like something is wrong.

That’s okay. Trust that instinct. It’s better you waste a few bucks throwing out a real vape cartridge than it is to take a gamble on a fake one and lose.

We hope this brief article helps you avoid fake vapes. Stay safe out there! 

 


StaffJune 24, 2021
extraction-scaled.jpg?fit=1200%2C772&ssl=1

4min26930

Precision Extraction Solutions and Cascade Sciences have entered into a definitive merger agreement to create Sinclair Scientific, forming the largest cannabis and hemp extraction equipment and services company in the world with an unparalleled portfolio of technological offerings. the two operators have combined annual revenue of over $100 million.

The global cannabis extract market size is expected to be valued at $28.5 billion by 2027, according to a new report published by Grand View Research, Inc. It is projected to expand at a CAGR of 16.6% over the forecast period. Based on product type, cannabis extracts are classified into oils and tinctures.

The merger between Precision and Cascades is one of the first major consolidations in the cannabis extraction equipment and life sciences space. Sinclair Scientific said it plans to add more brands to its portfolio, including highly innovative and disruptive technologies to further its growth.

“This is a major milestone in the cannabis extraction equipment and life sciences space and we are thrilled about the unique opportunities this merger will create for our customers, as well as our employees, business partners, and shareholders,” said Marc Beginin, CEO of Precision Extraction Solutions. “Our combined company will have the most respected, recognized, and storied brands in the global cannabis extraction industry, and together we will create even brighter futures. This combination offers significant value to our stakeholders in a company firmly positioned for exponential growth.”

The CEOs of both Precision and Cascade are stepping down. Beginin and  Lee Kearney have each taken seats as directors on the newly formed board of Sinclair Scientific. The first act of Sinclair’s board was to unanimously appoint Doug Dowd as the Chief Executive Officer of Sinclair Scientific. Dowd brings more than 35 years of executive leadership experience with some of the largest life sciences companies in the world (including Thermo Fisher and Avantor Sciences) and a proven track record of management expertise and operational results. Most recently, Mr. Dowd served as president of Ricca Chemical Company, a leading manufacturer of analytical solutions and standards in North America.

The newly formed entity will have offices, warehousing, and production facilities throughout the United States including CaliforniaColoradoMichiganNew Jersey, and Oregon.

Lee Kearney, CEO of Cascade Sciences, added, “Through merging Precision and Cascade, we are creating an unmatched platform for both U.S. and international growth. Our combined brands and businesses mean increased scale, solidifying our position as the world’s premier provider of the most innovative equipment, robust technology, and unparalleled customer service in the extraction industries. We greatly admire the business that the Precision team has built, and we are excited to work with them to integrate our two companies and execute on the attractive growth opportunities ahead.”


StaffApril 29, 2021
shutterstock_682670464.jpg?fit=1200%2C799&ssl=1

8min23220

Editors Note: This is a guest post.

Terpenes can be found in almost all species of flora. They are chiefly responsible for the aromatic and flavor diversity in the plant kingdom.  Simple chemical compounds, terpenes are created to help plants defend themselves against threats and to attract beneficial species.  In Cannabis sativa, terpenes are produced in the resin glands along with the cannabinoids and often work together to enhance or alter the effects of one another. This list houses information about the most common and abundant terpenes found in cannabis, including their flavors and known medical benefits. For full guides and artistic visualizations, view the terpene infographics from Goldleaf.

LINALOOL

This terpene’s hallmark is its floral scent, reminiscent of sharp and sweet wildflowers. It is also found in lavender, laurel, birch and rosewood.  It has calming and sedative properties and can help relieve anxiety.

Medical value: analgesic, anti-epileptic, anti-depressant, anti-anxiety.

β- CARYOPHYLLENE

Known to have an aroma that is peppery, woody and spicy, this is the only terpene proven to interact with the endocannabinoid system (CB2) in our bodies. It is also found in basil, oregano, pepper, and cinnamon leaves.

Medical value: anti-inflammatory, analgesic, anti-spasmodic, sleep aid.

α PINENE

The most common and abundant naturally occurring terpene, it is a main contributor to cannabis’ tell-tale piney aroma. It is also found in many conifer species and herbs such as sage. It is known to enhance memory and alertness.

Medical value: anti-inflammatory, bronchodilator.

MYRCENE

Described as earthy and musky, this terpene is prevalent in most all strains of cannabis. It is known to enhance THC uptake and contributes to the sedating and calming effects often associated with indica. Myrcene is also found in mango, hops, thyme, and citrus.

Medical value: analgesic, anti-inflammatory, antibacterial, antifungal, sedative.

HUMULENE

Another strong contributor to the tell-tale “earthy” aroma of cannabis, this terpene is also present in hops and coriander. Humulene can act as an appetite suppressant and offers potent anti-inflammatory abilities.

Medical value: anti-inflammatory, anti-bacterial, analgesic.

TERPINEOL

Due to its pleasant aroma reminiscent of lilac and flower blossoms, it is often used in cosmetic products such as soaps. It is often found in higher concentrations alongside pinene, which unfortunately may mask its scent.  It is known to have relaxing effects.

Medical value: antibacterial, anti-anxiety, immunostimulant.

LIMONENE

This terpene is normally found in higher concentrations in sativa varieties and is associated with elevated mood. It can be found in the rinds of various citrus fruits, juniper, and mint. Limonene has a unique ability to quicken the absorption of other terpenes in the body.

Medical value: anti-anxiety, anti-depressant, gastroesophageal reflux, antifungal.

TERPINOLENE

Having a piney aroma with notes of herbs and wildflower, this terpene is often used in perfumes and as an insect repellant.  It is also found in rosemary, sage, and Monterey cypress. Terpinolene has been shown to exhibit antioxidant and anticancer effects and as a sedative.

Medical value: sedative, anti-tumor.

GERANIOL

Creating a delightfully sweet smell akin to roses, this terpene is present in geraniums, lemons, and tobacco and is often used in perfumes and other cosmetics. It is also an effective mosquito repellant.

Medical value: neuroprotective, anti-fungal, anti-tumor.

VALENCENE

Getting its name due to its high concentration in Valencia Oranges, this terpene has a citrusy sweet aroma.  It is also found in grapefruits, tangerines, and some herbs. It is common in many strains of cannabis and is shown to be a powerful tick and mosquito repellant.

Medical value: *still being researched.

OCIMENE

Found in a wide variety of botanicals, it is known for its sweet and woodsy scent. Plants use ocimene to defend themselves against pests in nature. It is also found in mint, parsley, pepper, basil, orchids, and kumquats.

Medical Value: antifungal.

BISABOLOL

Also carrying a distinct floral aroma, this terpene is prevalent in chamomile and likely responsible for many of its medical benefits. It can be used to heal wounds due to its antibacterial properties.

Medical value: antibacterial, anti-inflammatory.

EUCALYPTOL

Commonly associated with the Eucalyptus tree, this terpene has an iconic spicy and fresh scent. It is used in a variety of products such as cough suppressants, mouthwash, and deodorants and has many proven uses. It is a mainstay in traditional Chinese and ayurvedic medicine.

Medical value: analgesic, antibacterial, anti-inflammatory, sleep aid.

_

Written by: Alfonso Colasuonno, Researcher and Writer at Goldleaf Ltd

Sources: National Center for Biotechnology Information (NCBI); SC Labs Inc; “Cannabis sativa: The Plant of the Thousand and One Molecules“, Andre CM, Hausman JF, Guerriero G.

 


Debra BorchardtDecember 9, 2020
dispensary.jpg?fit=960%2C640&ssl=1

5min16160

Looking back at 2020, the Brightfield Group determined the cannabis product shelf space winners. A review of the first three quarters provided a snapshot of which products cannabis consumers wanted most. This type of information is invaluable to producers and dispensary owners alike. The producers can make sure that they have these products in their portfolio and dispensaries can make sure they stock their shelves with the items that customers want.

Increased 2020 Shelf Space:

  1. Candy
  2. Cartridges/Pods
  3. Resin/Rosin
  4. Disposable Pens
  5. Baked Goods

Candy

Brightfield’s report found that since January 2020, the candy category has captured 12% of the shelf and in August held 14% of the shelf its largest position to date. The category has grown by 41% in 2020. The report also noted that the shelves saw a shift towards luxury and premium prices.  Consumers have also been drawn to natural marketing and like options that are vegan, non-GMO, and additive-free.

Top Candy Flavors:

  1. Raspberry
  2. Watermelon
  3. Strawberry
  4. Fruity
  5. Chocolate

Top Candy Brands

  • Cheeba Chews
  • Smokiez Edibles
  • Kiva Confections
  • Wyld

Vapes

Despite the vape crisis of 2019, vape products commanded 22% of the shelf space for 2020. The report found that cartridges and pods grew shelf space by 3% in 2020. 74% of these products were in 500mg packages and a majority were marketed for relaxation and stress relief. The price preference was the opposite of candy, but that’s probably because vapes in general are more expensive. Budget-priced products saw an increase in shelf space and premium-priced products saw shelf space declines.

Top Vape Attributes

  1. Relaxation
  2. Stress
  3. Focus & Creativity

Top Vape Brands

  • Stiiizy
  • Jetty Extracts
  • Raw Garden
  • Curaleaf
  • Pure Vape
  • Alpine

Resin & Rosin

THC concentrates continue to win over new consumers. The product packs a bigger punch than vapes or traditional flower that typically deliver 15%-35% THC. These concentrates can provide doses of 60%-90% THC. While dabbing shatter, wax, or crumble has been the predominant concentrate method, rosin and live resin are coming on strong. Rosin is made with a solventless method that relies only on heat and pressure to extract cannabinoids and delivering a “cleaner” dab. Live resin is made with more traditional extraction methods and preserves the terpenes. This category increased its shelf space by 3%, while the shatter, wax and crumble categories fell.

Disposable Pens

Brightfield found that while disposable pens only garnered 4% of the dispensary shelf space, distribution grew by 68% in 2020. Once again, stress relief was the top choice for this consumer. The smaller products having 300mg grabbed the most space within the category and tend to be the most affordable. It’s the product of choice among the price-conscious consumer.

Baked Goods

Marijuana brownies are the OG of cannabis consumers, but the inconsistent response time for consumers make these products less desirable. Customers may react quickly or slowly after consuming a cookie or brownie and this lack of consistency is an issue. Only 3% of the distribution goes to this category. Still, in 2020 there was a 40% increase in shelf space for baked goodies.

Brightfield’s Top ten Product Launches of 2020:

  1. Care by Design – 8:1 Vape Cartridge
  2. Claybourne Co. – 501St OG Bud
  3. Kiva Confections – Midnight Blueberry Camino Gummies
  4. Stiiizy – wedding Cake Live Resin Pod
  5. Raw Garden Sleeroy G Pod
  6. Yummi Karma – YK Drops – Draft Away
  7. West Coast Cure – Venom Og Live Resin Sauce
  8. Pacific Stone – 505 Sour Hybrid Bud
  9. Heavy Hitters – Forbidden Fruit Cartridge
  10. Connected Cannabis Co. – 100% Live Resin Disposable

 

 


StaffAugust 18, 2020
shutterstock_1789366847-scaled.jpg?fit=1200%2C789&ssl=1

4min27490

Under the coverage of a Health Canada Schedule 1 Controlled Drugs and Substances Dealer’s License, Mydecine Innovations Group, Inc., (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) (“Mydecine™” or the “Company”) announced that it is the first organization to exercise its cGMP capabilities under a special license to legally produce, transfer, sell, and export pharmaceutical-grade psilocybin, naturally derived from whole-mushroom extraction.

Mydecine™ has the full range of capabilities to extract fungi’s natural psychedelic compounds, such as psilocybin and psilocin from certain species of fruiting body mushrooms all the way through to distribution. Mydecine™ also has the ability to conduct the most advanced techniques to produce purified pharmaceutical-grade extract, then legally export its finished byproducts to its various research partners throughout the world, including but not limited to the Imperial College of London and Johns Hopkins University.

The Company is also capable of supporting commercial research institutions with product donations, including charitable contributions to provide its purified extracts and formulations to end-of-life distressed patients. The announcement comes on the heels of a recent landmark decision by Health Canada to permit four terminally ill patients to consume psilocybin mushrooms to ease their distress. This historic decision establishes a precedent that will pave the way for a wider adoption of psilocybin-based therapies.

“Mydecine’s breakthrough to legally supply naturally-sourced psilocybin within our spore-to-sale™ process will be a major advancement for mental therapeutics, due to the fact that these unique psychedelic compounds are both safe and effective for afflictions, such as depression, anxiety, and PTSD,” quoted Damon Michaels, COO and Co-Founder of Mydecine™.

There is still debate as to which is more successful in psychedelic-based treatments between naturally derived psilocybin or the use of a synthetic form. Given Mydecine’s full legal ability to access both types of active compounds, the Company is poised to internally answer that question as well as aid various qualified groups also conducting this type of research. In theory, there are a plethora of added benefits in regard to the entourage effect of naturally-sourced psilocybin versus the synthetic route. Additionally, Mydecine™ is developing a number of unique API’s from their naturally-sourced cGMP psychedelic extracts. Mydecine™ will also be conducting R&D to produce novel proprietary formulations by synergizing psychedelic fungi compounds with other various API’s; Mydecine™ will then attach their formulations to their exclusive delivery mechanisms. Mydecine™ plans to utilize these psychedelic medicinal formulations in various clinical environments around the world in aspiration to better the lives of many.

The Company notes that although several international companies and research institutions are permitted to utilize synthesized psilocybin, the process is extremely challenging and cost prohibitive with a single gram having the price tag of thousands of dollars. Being able to legally extract psilocybin from its natural source, Mydecine™ will hope to reduce these significant costs and improve the scalability of world-class research initiatives and novel therapies.

CEO and Director of Mydecine™, Joshua Bartch stated, “We are extremely grateful to have the ability to provide cGMP psychedelic API’s to qualified organizations, research partners, nonprofits, and clinical groups throughout the globe. We believe the reason current psilocybin-based research initiatives come with a very high cost using inefficiently produced synthetic psilocybin is simply due to a lack of capabilities and legal restraints. Mydecine’s legal capabilities through the dealer’s license will incorporate our range of abilities, which will be valuable for naturally-sourced medicine paired with new-age technology. We believe our achievement is the first-of-its-kind.”


AxisWireAugust 18, 2020
logo_mydecine-2.png?fit=850%2C531&ssl=1

9min76420

Being Facilitated Under a Schedule 1 Health Canada Dealer’s License

DENVER, Colorado, USA, August 18, 2020 /AxisWire/ Mydecine Innovations Group, Inc., (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) (“Mydecine™” or the “Company”) is pleased to announce it is the first organization to exercise its cGMP(₁) capabilities under a special license to legally produce, transfer, sell, and export pharmaceutical-grade psilocybin, naturally derived from whole-mushroom extraction.

Under the coverage of a Health Canada Schedule 1 Controlled Drugs and Substances Dealer’s License, Mydecine™ has the full range of capabilities to extract fungi’s natural psychedelic compounds, such as psilocybin and psilocin from certain species of fruiting body mushrooms all the way through to distribution. Mydecine™ also has the ability to conduct the most advanced techniques to produce purified pharmaceutical-grade extract, then legally export its finished byproducts to its various research partners throughout the world, including but not limited to the Imperial College of London and Johns Hopkins University.

The Company is also capable of supporting commercial research institutions with product donations, including charitable contributions to provide its purified extracts and formulations to end-of-life distressed patients. The announcement comes on the heels of a recent landmark decision by Health Canada to permit four terminally ill patients to consume psilocybin mushrooms to ease their distress. This historic decision establishes a precedent that will pave the way for a wider adoption of psilocybin-based therapies.

“Mydecine’s breakthrough to legally supply naturally-sourced psilocybin within our spore-to-sale™ process will be a major advancement for mental therapeutics, due to the fact that these unique psychedelic compounds are both safe and effective for afflictions, such as depression, anxiety, and PTSD,” quoted Damon Michaels, COO and Co-Founder of Mydecine™.

There is still debate as to which is more successful in psychedelic-based treatments between naturally derived psilocybin or the use of a synthetic form. Given Mydecine’s full legal ability to access both types of active compounds, the Company is poised to internally answer that question as well as aid various qualified groups also conducting this type of research. In theory, there are a plethora of added benefits in regard to the entourage effect(₂) of naturally-sourced psilocybin versus the synthetic route. Additionally, Mydecine™ is developing a number of unique API’s(₃) from their naturally-sourced cGMP psychedelic extracts. Mydecine™ will also be conducting R&D to produce novel proprietary formulations by synergizing psychedelic fungi compounds with other various API’s; Mydecine™ will then attach their formulations to their exclusive delivery mechanisms. Mydecine™ plans to utilize these psychedelic medicinal formulations in various clinical environments around the world in aspiration to better the lives of many.

The Company notes that although several international companies and research institutions are permitted to utilize synthesized psilocybin, the process is extremely challenging and cost prohibitive(₄) with a single gram having the price tag of thousands of dollars. Being able to legally extract psilocybin from its natural source, Mydecine™ will hope to reduce these significant costs and improve the scalability of world-class research initiatives and novel therapies.

CEO and Director of Mydecine™, Joshua Bartch stated, “We are extremely grateful to have the ability to provide cGMP psychedelic API’s to qualified organizations, research partners, nonprofits, and clinical groups throughout the globe. We believe the reason current psilocybin-based research initiatives come with a very high cost using inefficiently produced synthetic psilocybin is simply due to a lack of capabilities and legal restraints. Mydecine’s legal capabilities through the dealer’s license will incorporate our range of abilities, which will be valuable for naturally-sourced medicine paired with new-age technology. We believe our achievement is the first-of-its-kind.”

1 Current Good Manufacturing Practices. GMP is a system for ensuring that products are consistently produced and controlled according to the best quality standards.

2The“entourage effect” is a proposed mechanism by which active compounds act synergistically to modulate the overall effects of multiple active compounds working together to produce a polypharmaceutical medicine.

3Active Pharmaceutical Ingredient/s are single or poly ingredients in pharmaceutical medicines that are biologically active.

4 Current synthesized psilocybin applied to recent psychedelic research sells for ~$7-10k USD per gram.

 

About Mydecine Innovations Group Inc.
Mydecine Innovations Group™is a publicly traded life sciences parent company with offices in Denver, CO and Vancouver, BC. Mydecine™ is dedicated to the development and production of adaptive pathway medicine, natural health products and digital health solutions stemming from fungi. Mydecine’s experienced cross functional teams have the dynamic capabilities to oversee all areas of medicine development, including synthesis, genetic research, import/export, delivery system design, clinical trial execution, through to product commercialization and distribution. By leveraging strategic partnerships with scientific, medical, military, and clinical organizations, Mydecine is positioned at the forefront of psychedelic medicine naturally derived from fungi, therapeutic solutions, and fungtional™ mushroom vitality products. Our portfolio of unified companies, including Mydecine Health Sciences™, Mindleap Health™, and NeuroPharm™ focus on providing innovative and effective options that can provide millions of people with a healthier quality of life.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof. This news release contains forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company.Readers are cautioned that these forward-looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected including,without limitation, the availability and continuity of financing, the ability of the Company to adequately protect and enforce its intellectual property, the Company’s ability to bring its products to commercial production, continued growth of the global adaptive pathway medicine, natural health products and digital health industries, and the risks presented by the highly regulated and competitive market concerning the development, production, sale and use of the Company’s products. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. These forward-looking statements are made as of the date hereof and the Company does not assume any obligation to update or revise them to reflect new events or circumstances save as required under applicable securities legislation. This news release does not constitute an offer to sell securities and the Company is not soliciting an offer to buy securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. This news release does not constitute an offer of securities for sale in the United States. These securities have not and will not be registered under United States Securities Act of 1933, as amended, or any state securities laws and may not be offered or sold in the United States or to a U.S. Person unless so registered, or an exemption from registration is relied upon.


Julie AitchesonJune 11, 2020
Blinc2.png?fit=960%2C960&ssl=1

6min16990

The summer of 2019 pales in comparison to the turmoil of pretty much every month of 2020 thus far, but was still notable for at least one high-profile public health crisis. August 2019 saw a noted rise in vaping-related illnesses. The vaping crisis prompted the Food and Drug Administration to initiate comprehensive laboratory testing and ongoing investigations of cases in order to regulate the use of vaping products.

Vape sales for key states hit a high of $160 million in August 2019 according to the new State of Legal Cannabis report by Arcview and BDSA. By September, those sales dropped to $126 million.  Once it was determined that illegal manufacturers were the root of the problem, branded vape sales started to slowly recover. Fourth-quarter 2019 sales still showed signs of decline, but in December sales picked up by 11%.

States and the vaping industry are still waiting on concrete federal guidelines, and in the meantime, many manufacturers of vaping hardware and associated products are downsizing or disbanding due to the one-two punch of the vape crisis and Covid-19. 

Blinc Remains Resilient

There is at least one hopeful story on the vape industry horizon, however, and that is the resilient growth and success of The Blinc Group. The Blinc Group’s business model is built on a tripartite foundation of innovation, quality, and safety, and it seems to be working. Where many companies suffered lethal blows from the vape crisis and Covid-19, The Blinc Group has maintained a focus on expansion and upgrading their facilities to improve safety standards. I recently had the opportunity to speak with Arnaud Dumas du Rauly, CEO of The Blinc Group. 

Arnaud Dumas du Rauly is also the ISO (International Organization for Standardization) Chairman of Standards on Vaping Products and the Chairman of the European Commission on Standards on Vaping Products. In other words, The Blinc Group is serious about safety. This focus led to slower initial growth and higher product pricing than the industry standard, but with earnings for 2020 already matching earnings for all of 2019, The Blinc Group is seeing a major return on its investment. 

During our interview, du Rauly spoke passionately about emissions, one of the industry’s primary safety issues. Because oils can undergo a change of state when they are vaporized, it is not possible to fully assess the potential toxicity of a product without testing emissions, typically using something called a “puffer machine”. This type of testing is not yet required in the U.S., but du Rauly is evangelical about its importance, not just for his company but industry-wide.

When the Covid-19 crisis hit and customers became more health-conscious in their buying behavior, The Blinc Group found itself in high demand with its start-to-finish supply chain control, a ten-year relationship with manufacturing facilities in China (which enabled them to keep their production on track as Covid-19 peaked there), and components that are ISO and GMP (Good Manufacturing Practice) compliant. It also allowed them to consolidate a position in the Canadian market, which is a highly regulated environment that few vaping product manufacturers in the U.S. are prepared to navigate. 

Arnaud Dumas du Rauly admits that research has not yet caught up with the cannabis industry in terms of product safety, but in his own words, “the DNA of the company is making sure that safe products get out there.” The Blinc Group’s current trajectory suggests that success is also part of their genetic makeup.

 


StaffMay 13, 2020
shutterstock_660308902-scaled.jpg?fit=1200%2C746&ssl=1

9min54012

Ever since recreational cannabis has stolen the stage, people tend to forget that cannabis is one of the oldest and most trusted medicines on the planet.

The medicinal properties within the plant are responsible for managing the symptoms associated in patients suffering from Epilepsy, Autism, Crohn’s Disease, Cancer, PTSD, and Chronic Pain to name just a few.

These brands have developed some of the best practices and formulations in the industry to treat a myriad of ailments with patents pending across the globe.

Our team decided to break down a list of the most respected medical brands and products within the cannabis industry globally.

Here they are:

 

1.) Charlotte’s Web:

More than just CBD: CBD plus naturally-occurring phytocannabinoids, terpenes, flavonoids and more in every CBD oil serving. The team from Charlotte’s Web uses limited, select ingredients to ensure you have the absolute best hemp extract possible. Their CBD oils include Charlotte’s Web premium hemp extract, carrier oil, and flavor. That’s it. Their products are U.S. Hemp Authority Certified. Charlotte’s Web CBD oils are whole-plant extracts that include a variety of of beneficial compounds, including phytocannabinoids, terpenes, flavonoids, and essential fatty acids.

 

2.) Aunt Zelda’s:

Aunt Zelda’s is a pioneering, data-driven developer of cannabis-based plant medicines. Our products are the result of years of research and development by founders, Mara Gordon and Stewart Smith, in consultation with knowledgeable physicians and world-renowned researchers.

Utilizing proven time-tested extraction processes improved with modern technology, Aunt Zelda’s offers medicines of precisely measured potency and purity that empower patients to dose to the milligram and unlock the therapeutic potential of cannabis.

If you prefer to obtain lab tested products created for specific ailments, Aunt Zelda’s will help you get there!

Aunt Zelda’s mission is to alleviate patient suffering through medical cannabis.  We help you, our patients, live fulfilling, healthy lives.

They provide unmatched expertise in the correct use of medical cannabis matched to disease-specific products with the highest purity in California.

Their goal is to create a positive and supportive community for medical cannabis users. They aspire to be your trusted source of cannabis resources and its safe, effective and responsible use

 

3.) HOPE Grows for Autism:

Formulation by: Zelira Therapeutics

HOPE is a Proprietary formulation specifically to address patient symptoms associated with Autism Spectrum Disorder.  The HOPE® Franchise has received support from organizations such as HOPE Grows for Autism, a leading autism advocacy group based in Pennsylvania. It has been the top performing product within the state and will soon be available for patients in Louisiana and throughout the US and Australia. 

In a company press release in December 2019, Zelira Therapeutics leadership said, “Our company will have the ability to distribute the HOPE® portfolio along with our additional products through licensing agreements with multi-state and international operators…”

HOPE 1 and HOPE 2 are part of a growing family of proprietary medical marijuana formulations. HOPE™ is created by extracting, isolating, and then re-assembling the medicinal compounds from the marijuana plant to achieve specific, targeted effects. HOPE™ was formulated with autism in mind and has quickly proved to be beneficial to other chronic conditions such as chronic pain, anxiety, neuropathy and others. HOPE™ has since become its manufacturer’s best-selling tincture.

 WHAT FORMS OF HOPE ARE AVAILABLE?

Available as a tincture, blended in 100% olive oil.

WHAT MAKES UP HOPE?

THC + CBD + Terpenes

Found in the trichomes of the plant, terpenes are plant oils with unique aromas and distinctive​ flavors (pine, citrus, mint) and are known to play​ a key role on the overall effects of each strain. ​ Terpenes also play a key role in differentiating​ the flavor and scent of marijuana. Some terpenes​ might promote relaxation, while others energy or​ focus.

 

4.) Ilera Holistic Healthcare:

ALAFIA — which means ‘inner peace’ in the Nigerian “Yoruba” language — is scientifically formulated, lab tested and pesticide free. Currently on the market are two formulated PURE CBD tinctures: Isolate CBD with 500mg and 1000mg  and Full Spectrum CBD with 500mg and 1000mg.  This product is Additional CBD products will be released at dispensaries in the state of Louisiana only.

“Our vision has always been patient access and affordability,” said Chanda Macias, chief executive officer of Ilera Holistic Healthcare. “It was imperative for us to bring high-quality products that support health and wellness.  Patients now have the ability to purchase ALAFIA over the counter without a prescription anywhere it is available.”  Dr. Chanda Macias said back in January 2020

5.) Haleigh’s Hope:

Extra strength has double the concentration than the regular strength, allowing the consumer to take less oil but still get the same desired therapeutic effect as the regular strength. Extra Strength products are recommended for people over 100 lbs.

This organically grown, whole plant extract contains a broad spectrum of naturally occurring plant based compounds that are clinically proven to provide a powerful combination of antioxidants and neuroprotectants. Haleigh’s Hope® was created from a proprietary genetic plant strain that was carefully bred and cultivated over seven years to achieve a precise combination of clinically proven, therapeutic plant compounds..

Haleigh’s Hope® grows, extracts, produces, packages and ships 100% of our product from our facilities in Colorado. Because we have exclusive control over our products from seed to sale, we ensure the highest levels of quality and consistency in the industry. Every batch of our product is lab tested for safety and quality.

Safflower is a cold pressed seed oil that is non-GMO and organic, and does not need to be shaken.

Exclusively grown and manufactured in Colorado, USA.


Debra BorchardtOctober 2, 2019
vaping.jpg?fit=960%2C640&ssl=1

8min31890

Vape products, once considered the rising stars of the legal cannabis marketplace have struggled under the weight of the vaping crisis. Massachusetts banned all vape products for four months in order to err on the side of caution while the issue is investigated. Around the middle of August, vape product sales began dropping according to data from Headset, however, it seems the group may be slowly recovering. The following table was provided by Headset.

Sales in Nevada and Washington both began to pick back up, while California seems to have stabilized. Most consumers are learning that the issues with vapes stemmed from products purchased outside the regulated channels. 

A report from the CDC (Center for Disease Control) stated, “In addition, the report from Illinois and Wisconsin showed that nearly all THC-containing products reported were packaged, prefilled cartridges that were primarily acquired from informal sources such as friends, family members, illicit dealers, or off the street.”

It seems illicit market and unregulated vape producers were using thickening agents like Vitamin E with disastrous results. The industry, in general, has suggested that regulation will solve this issue and many are trying to convince the consumer that they can trust a regulated brand.

“The widely publicized public health issue relating to the use of liquid vapes is something that SLANG takes extremely seriously,” said SLANG Worldwide (OTC: SLGWF) CEO Peter Miller. “We encourage investigation and research into the causes of this issue and hope that our collective understanding of the results leads to more thorough and effective regulation of the industry.”

SLANG said it is not aware of any of its products being identified as a contributor to any of the recent illnesses associated with vaping technology. SLANG is not currently operating in Massachusetts and had postponed plans to enter that state. It doesn’t expect to be adversely impacted by Massachusetts’ temporary ban on vaping products.

1933 Industries (CSE: TGIF) (OTCQX: TGIFF) said, “All our branded THC and CBD vape products do not contain vitamin E acetate, vegetable glycerin, or propylene glycol. All our products are made with ingredients that are known to be safe for consumers. All packaging contains our product ingredients, which are also listed on our website. Each and every product is third-party lab tested, and the results can be tracked via a QR code.”

Testing Boom

Of course, in order to be sure testing is the best way to go and this crisis could present an opportunity for the lab group to capitalize. CannaSafe, California’s leading accredited cannabis testing laboratory said it will expand contaminant testing to Vitamin E additives, in response to ongoing concerns around consumer vaping safety. CannaSafe is the first laboratory to offer this service and will also provide testing for additional additives including medium-chain triglycerides, vegetable glycerin, and propylene glycol in the coming weeks.

“Trusted cannabis companies are taking it upon themselves to impose high-quality standards on consumer products, and we are ready to work with any business that wants to show customers that their products are free of toxic additives,” said Aaron Riley, CEO of CannaSafe. “We also urge brands and retailers to share test results with their customers as a gesture of good faith.”

Modern wellness company, dosist, is the first brand to voluntarily undergo Vitamin E testing with CannaSafe. Other brands that will utilize Cannasafe’s testing technology include Orchid Essentials, Select, Heavy Hitters, Stiiizy, King Pen, Lowell Herb Co., Pure Vape, Tikun, and Raw Garden. The Vitamin E test is available to brands and manufacturers across the state for an additional $225.

 


Don't Miss This Week's Groundbreaking News

Join the thousands of subscribers who stay informed with GMR's exclusive news briefs delivered directly to your inbox every Friday afternoon.

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 3 days

Happy Friday! Marijuana Money July 23, 2021

@GreenMarketRpt – 5 days

RT : I spoke with to discuss cannabis stock options worth consideration, and why U.S. MSOs pique his interest…

Back to Top